In-hospital use of continuous glucose monitoring may offer improvements in glycemic control and reduced exposure to COVID-19 for healthcare professionals.
Prediabetes is not associated with cognition after stroke, whereas type 2 diabetes increases the risk for lower poststroke cognitive function.
The management of painful diabetic peripheral neuropathy requires the use of effective agents that also may aid in improving sleep and mood.
Several cardiac and kidney biomarkers may be used to identify older adults with peripheral neuropathy.
After obtaining a more detailed history, it was discovered that the patient had been reusing insulin needles and was not rotating sites for insulin injection.
COVID-19 may affect treatment for patients with type 2 diabetes and necessitates re-evaluation of medications based on existing evidence.
Hyperglycemia may worsen outcomes in COVID-19 due to a rapid inflammatory response and increased glycosylation of the ACE2 receptor.
Higher intake of manganese is associated with a lower type 2 diabetes risk among postmenopausal women, independent of known risk factors.
Diabetes and/or uncontrolled hyperglycemia occur frequently among hospitalized patients with COVID-19 and are associated with worse outcomes.
The most common comorbidities among patients hospitalized with COVID-19 in the New York City area are hypertension, obesity, and diabetes.
